510(k) K222779

Revogene by Meridian Bioscience, Inc. — Product Code OOI

K222779 is an FDA 510(k) premarket notification submitted by Meridian Bioscience, Inc. for the device "Revogene". The FDA issued a decision of Substantially Equivalent on Jan 26, 2023. The device falls under product code OOI (Real Time Nucleic Acid Amplification System), a Class II device regulated under 21 CFR 862.2570. Meridian Bioscience, Inc. has 37 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jan 26, 2023
Date Received
Sep 14, 2022
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Real Time Nucleic Acid Amplification System
Device Class
Class II
Regulation Number
862.2570
Review Panel
CH
Submission Type
510(k) Exempt

The system is a clinical multiplex instrument intended to measure and sort multiple signals generated my multiple probes, intercalating dyes, or other ligands in an assay from a clinical sample. Signals may be generated by fluorescence or other phenomena and may be measured using filters on a photodiode or other detector. It may integrate sample and/or reagent handling, amplification, dedicated instrument control, data acquisition software, raw data storage mechanisms and other essential hardware components along with the signal reader unit. The system is used with specific assays to comprise an assay test system.

Need the full FDA record for Meridian Bioscience, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K222779. Report a data issue: hello@regdatalab.com.